🇺🇸 FDA
Patent

US 8524247

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 8524247 (Rabies virus-based recombinant immunocontraceptive compositions and methods of use) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/5256, A61K2039/542